DOI: 10.1021/acsmedchemlett.6c00397 ISSN: 1948-5875
Novel Compounds as SARS-CoV-2-Related 3C-Like Protease Inhibitors for Treating Coronavirus Infections
Ram W. SabnisAbstract
Provided herein are novel compounds as SARS-CoV-2-related 3C-like protease (3CLPRO) inhibitors, pharmaceutical compositions, use of such compounds in treating coronavirus infections, and processes for preparing such compounds.